Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology
暂无分享,去创建一个
Javier Martín | J. Pers | A. Saraux | V. Devauchelle-Pensec | G. Espinosa | Marcus John Beasley | R. Cervera | E. Carnero-Montoro | M. Acosta-Herrera | F. Hiepe | L. Beretta | G. Barturen | M. Kerick | S. Jousse-Joulin | E. de Ramón | T. Witte | D. Cornec | C. Chizzolini | N. Hunzelmann | M. Brandão | F. Farinha | G. Stummvoll | N. Ortego | M. Lehner | B. Lauwerys | C. Vasconcelos | R. Ortega-Castro | R. Lories | M. Gerosa | T. Schioppo | R. Lesche | R. Aguilar-Quesada | M. Zauner | S. Dulić | E. De Langhe | A. Balog | S. Babaei | Z. Makowska | M. Teruel | A. Buttgereit | I. Almeida | A. Campar | R. Faria | A. Marinho | Esmeralda Neves | A. Tavares | B. Vigone | I. Rodríguez-Pintó | D. Belz | N. Baerlecken | M. Aguirre-Zamorano | M. Castro-Villegas | A. Escudero-Contreras | E. Raya | C. Artusi | J. Ducreux | A. Maudoux | Donatienne Wynar | M. Bocskai | M. Deák | G. Kádár | V. Gerl | Silvia Thiel | M. Maresca | R. B. Alonso | I. Quintero | María Concepción Fernández Roldán | Inmaculada Jiménez Moleón | L. Kovács | E. López-Isac | E. Collantes | D. González-Serna | M. Mantecón | Alfonso Corrales Martínez | A. Zuber | A. López‐Berrio | H. Navarro‐Linares | M. Alarcón-Riquelme | D. González‐Serna | Anne‐Lise Maudoux | Héctor Navarro‐Linares | Ana Tavares | M. R. Maresca
[1] S. Assassi,et al. Type I interferon dysregulation in Systemic Sclerosis. , 2020, Cytokine.
[2] Javier Martín,et al. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients , 2020, Annals of the Rheumatic Diseases.
[3] Simon C. Potter,et al. Complement genes contribute sex-biased vulnerability in diverse illnesses , 2020, Nature.
[4] Javier Martín,et al. Genomic opportunities for drug repositioning in systemic seropositive rheumatic diseases , 2020, Expert review of clinical immunology.
[5] Ami A. Shah,et al. HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry , 2019, Proceedings of the National Academy of Sciences.
[6] B. Hinz,et al. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases , 2019, Nature Reviews Rheumatology.
[7] Ami A. Shah,et al. Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile , 2019, Annals of the rheumatic diseases.
[8] Howard Y. Chang,et al. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways , 2019, Nature Communications.
[9] Javier Martín,et al. Towards a Better Classification and Novel Therapies Based on the Genetics of Systemic Sclerosis , 2019, Current Rheumatology Reports.
[10] J. Varga,et al. Emerging targets of disease-modifying therapy for systemic sclerosis , 2019, Nature Reviews Rheumatology.
[11] Gautier Koscielny,et al. Open Targets Platform: new developments and updates two years on , 2018, Nucleic Acids Res..
[12] M. Mayes,et al. Associations of Multiple NOTCH4 Exonic Variants with Systemic Sclerosis , 2018, The Journal of Rheumatology.
[13] J. Greenbaum,et al. Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression , 2018, Cell.
[14] Jesper Tegnér,et al. Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients , 2018, Human molecular genetics.
[15] C. Denton,et al. Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis , 2018, Arthritis & rheumatology.
[16] A. García-Sáez,et al. Bax, Bak and beyond — mitochondrial performance in apoptosis , 2018, The FEBS journal.
[17] A. Barton,et al. CD4+ and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in untreated early arthritis: implications for causal gene identification , 2018 .
[18] A. Letai,et al. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis , 2017, Science Translational Medicine.
[19] Jeremy R. B. Newman,et al. Disease-specific biases in alternative splicing and tissue-specific dysregulation revealed by multitissue profiling of lymphocyte gene expression in type 1 diabetes , 2017, Genome research.
[20] T. Vyse,et al. Profiling RNA-Seq at multiple resolutions markedly increases the number of causal eQTLs in autoimmune disease , 2017, bioRxiv.
[21] C. Wijmenga,et al. Context-specific effects of genetic variants associated with autoimmune disease , 2017, Human molecular genetics.
[22] R. Salter,et al. Dnase1L3 Regulates Inflammasome-Dependent Cytokine Secretion , 2017, Front. Immunol..
[23] J. Belmont,et al. The 2017 international classification of the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.
[24] E. Dermitzakis,et al. Mapping eQTLs with RNA-seq reveals novel susceptibility genes, non-coding RNAs and alternative-splicing events in systemic lupus erythematosus , 2017, Human molecular genetics.
[25] A. Hofman,et al. Identification of context-dependent expression quantitative trait loci in whole blood , 2016, Nature Genetics.
[26] Ge Tan,et al. TFBSTools: an R/bioconductor package for transcription factor binding site analysis , 2016, Bioinform..
[27] Javier Martín,et al. Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways. , 2015, Journal of autoimmunity.
[28] Jeffrey T. Chang,et al. Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis , 2015, Arthritis & rheumatology.
[29] Viktor Martyanov,et al. Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms , 2015, PLoS Comput. Biol..
[30] Jane Worthington,et al. Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus , 2014, Arthritis & rheumatology.
[31] Annette Lee,et al. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. , 2014, American journal of human genetics.
[32] Oliver Distler,et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. , 2013, Arthritis and rheumatism.
[33] Tariq Ahmad,et al. Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway , 2013, Cell.
[34] M. Peters,et al. Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.
[35] Pedro G. Ferreira,et al. Transcriptome and genome sequencing uncovers functional variation in humans , 2013, Nature.
[36] M. Mayes,et al. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers , 2012, Current opinion in rheumatology.
[37] A. Sonnenberg,et al. Tetraspanin CD151 maintains vascular stability by balancing the forces of cell adhesion and cytoskeletal tension. , 2011, Blood.
[38] Annette Lee,et al. Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy , 2011, PLoS genetics.
[39] Andrey A. Shabalin,et al. Matrix eQTL: ultra fast eQTL analysis via large matrix operations , 2011, Bioinform..
[40] James Lyons-Weiler,et al. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. , 2011, Arthritis and rheumatism.
[41] Min Chen,et al. The complement system in systemic autoimmune disease. , 2010, Journal of autoimmunity.
[42] Annette Lee,et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus , 2010, Nature Genetics.
[43] S. Shete,et al. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. , 2010, Journal of autoimmunity.
[44] G. Gilkeson,et al. ETS transcription factors and regulation of immunity , 2006, Archivum Immunologiae et Therapiae Experimentalis.
[45] R. Grahame,et al. Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects. , 2004, Arthritis and rheumatism.
[46] P. Love,et al. TCR ζ chain in T cell development and selection , 1997 .
[47] P. Grant,et al. IgM receptor‐mediated transactivation of the IgH 3′ enhancer couples a novel Elf‐1‐AP‐1 protein complex to the developmental control of enhancer function. , 1995, The EMBO journal.
[48] C. Y. Wang,et al. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. , 1993, Science.
[49] N Rowell,et al. Systemic sclerosis. , 1968, British medical journal.
[50] Ash A. Alizadeh,et al. SUPPLEMENTARY NOTE , 1879, Botanical Gazette.
[51] L. Catrysse,et al. A20 in inflammation and autoimmunity. , 2014, Trends in immunology.
[52] S. Bhattacharyya,et al. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities , 2012, Nature Reviews Rheumatology.
[53] Ami A. Shah,et al. Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein , 2012, Annals of the rheumatic diseases.